← Back to headlines
DiaMedica Plans ReMEDy2 Interim Analysis by End of 2026
DiaMedica has outlined plans to conduct an interim analysis for its ReMEDy2 trial by the end of 2026, with a potential resample size of 300-700 patients.
7 May, 19:12 — 7 May, 19:12
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Business Ticker: Surprisingly many new orders for industry despite the war in Iran
just now
President Tinubu Appoints Arinola Ogbara-Banjoko to Commodity Exchange Board
just now
Lagos State Government announces dates for 2026 public service examinations
just now